CL — Cresco Labs Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual cashflow statement for Cresco Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-65.3	-92.8	-297	-216	-180
Depreciation
Deferred Taxes
Non-Cash Items	5.14	59.1	337	174	193
Unusual Items
Other Non-Cash Items
Changes in Working Capital	21.9	5.23	-29.1	13.5	15.2
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities	-25.2	-7.85	14.5	18.7	58.6
Capital Expenditures	-96.1	-89.3	-97.1	-86.1	-57.9
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-11.5	24.5	-66.9	49.6	13.3
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-108	-64.7	-164	-36.6	-44.6
Financing Cash Flow Items	50.8	-22.8	-76.4	-87.4	-43.6
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	48.9	161	235	-86.6	-26.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-83.9	87.8	85.3	-105	-13